Suppr超能文献

相似文献

1
Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer.
J Clin Endocrinol Metab. 2010 May;95(5):2187-94. doi: 10.1210/jc.2010-0063. Epub 2010 Mar 23.
2
Long-Term Efficacy of Lymph Node Reoperation for Persistent Papillary Thyroid Cancer: 13-Year Follow-Up.
Ann Surg Oncol. 2019 Jun;26(6):1737-1743. doi: 10.1245/s10434-019-07263-5. Epub 2019 Feb 28.
8
Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
Ann Surg Oncol. 2012 Sep;19(9):2951-7. doi: 10.1245/s10434-012-2380-9. Epub 2012 Apr 24.
9
Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer.
Laryngoscope. 2008 May;118(5):768-75. doi: 10.1097/MLG.0b013e318162cae9.
10
Tumor above the spinal accessory nerve in papillary thyroid cancer that involves lateral neck nodes: a common occurrence.
Arch Otolaryngol Head Neck Surg. 2002 Nov;128(11):1275-8. doi: 10.1001/archotol.128.11.1275.

引用本文的文献

1
A clinical study of microwave ablation for cervical lymph node metastasis from papillary thyroid cancer.
Front Endocrinol (Lausanne). 2025 Apr 25;16:1580765. doi: 10.3389/fendo.2025.1580765. eCollection 2025.
2
Ten-Year Outcomes of Radiofrequency Ablation for Locally Recurrent Papillary Thyroid Cancer.
Korean J Radiol. 2024 Sep;25(9):851-858. doi: 10.3348/kjr.2024.0208.
3
Ultrasound-Guided Ethanol Percutaneous Ablation Versus Rescue Surgery in Patients With Locoregional Recurrence of Papillary Thyroid Cancer.
Clin Exp Otorhinolaryngol. 2023 Nov;16(4):380-387. doi: 10.21053/ceo.2023.00689. Epub 2023 Aug 23.
4
Recurrent Differentiated Thyroid Cancer: The Current Treatment Options.
Cancers (Basel). 2023 May 10;15(10):2692. doi: 10.3390/cancers15102692.
6
Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response.
Front Endocrinol (Lausanne). 2023 Apr 20;14:1133958. doi: 10.3389/fendo.2023.1133958. eCollection 2023.
7
Diagnosis of cervical lymph node metastasis with thyroid carcinoma by deep learning application to CT images.
Front Oncol. 2023 Jan 26;13:1099104. doi: 10.3389/fonc.2023.1099104. eCollection 2023.

本文引用的文献

3
Phase II trial of sorafenib in metastatic thyroid cancer.
J Clin Oncol. 2009 Apr 1;27(10):1675-84. doi: 10.1200/JCO.2008.18.2717. Epub 2009 Mar 2.
4
Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer.
Laryngoscope. 2008 May;118(5):768-75. doi: 10.1097/MLG.0b013e318162cae9.
5
Thyroid carcinoma.
J Natl Compr Canc Netw. 2007 Jul;5(6):568-621. doi: 10.6004/jnccn.2007.0052.
6
Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer.
Arch Surg. 2006 May;141(5):489-94; discussion 494-6. doi: 10.1001/archsurg.141.5.489.
7
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
Thyroid. 2006 Feb;16(2):109-42. doi: 10.1089/thy.2006.16.109.
9
Papillary thyroid cancer: medical management and follow-up.
Curr Treat Options Oncol. 2005 Jul;6(4):323-38. doi: 10.1007/s11864-005-0036-8.
10
Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer.
Arch Otolaryngol Head Neck Surg. 2004 Oct;130(10):1214-6. doi: 10.1001/archotol.130.10.1214.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验